about
Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran.Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura.Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study.Prevalence of disease and relationships between laboratory phenotype and bleeding severity in platelet primary secretion defects.Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock.Metformin overdose causes platelet mitochondrial dysfunction in humans.Cerebral thrombosis and myeloproliferative neoplasms.Use of fresh-frozen plasma in 2012 at the Fondazione Ca' Granda Hospital of Milan: assessment of appropriateness using record linkage techniques applied to data routinely recorded in various hospital information systems.Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency.An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets.AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.Mechanistic insights from a refined three-dimensional model of integrin alphaIIbbeta3.Association between red cell distribution width and risk of venous thromboembolism.Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.Kinetics of Hepatitis B virus load during haemodialysis sessions and α-interferon: a prospective study.Severe Pneumonia Caused by Influenza A (H1N1) Virus Successfully Managed with Extracorporeal Life Support in a Comorbid Former Preterm Infant.Thrombosis after liver transplantation for hepatocellular carcinoma.Anticoagulant treatment with rivaroxaban in severe protein S deficiency.Circulating microparticles and risk of venous thromboembolism.Pregnancy outcome after a first episode of cerebral vein thrombosis.Red cell distribution width and the risk of cerebral vein thrombosis: A case-control study.A thrombotic storm.Hemostatic abnormalities in Noonan syndrome.Oral Surgery in Patients With Glanzmann Thrombasthenia: A Case Series.Thrombophilic and cardiovascular risk factors for retinal vein occlusion.A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency.Risk factors for idiopathic sudden sensorineural hearing loss and their association with clinical outcome.Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis.Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban.Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study.Conjunctival hemorrhagic events associated with imatinib mesylate.Particulate matter phagocytosis induces tissue factor in differentiating macrophages.Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia.What is behind a relapse of thrombotic thrombocytopenic purpura?An acquired factor VIII inhibitor in a myeloproliferative neoplasm presenting with severe retroperitoneal hemorrhage.Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban.Hemostatic abnormalities in patients with ehlers-danlos syndromeThe intra-assay reproducibility of thromboelastography in very low birth weight infantsPresentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran
P50
Q33376464-5570F1EB-15FA-4A46-8144-60F2AB5015A3Q33412212-2EABBFCE-B55E-43A6-9D78-91BC5ABBCE33Q33418909-345F33E9-71A7-40B0-8498-545047E1FA0DQ34658417-C2D1F369-F7D4-47F8-842D-5C78E7DD873FQ35115491-77EE6214-07F6-4F63-AD52-F8FA1AFB7063Q36928172-4C2B3126-FA3F-4ED4-89C6-4CFA9D64574DQ38248785-90367790-0042-4DAD-8108-698E898BA689Q38374428-38C41D5D-1EF9-426D-8B96-11C563476DF5Q38673228-3DBE2C93-E502-4189-8564-CE73B9B87063Q39143793-1B8EA437-D039-400C-ACE9-B8DC775558DFQ39939850-8D9B0C25-020C-4B3B-8757-D67033CF3424Q40571401-F41B14B5-8B35-4C9C-9DC8-CC35DCD7BC6DQ40684733-DB45B2DF-DEFF-44A6-81D6-9D881A2FFA2EQ40819096-68FDD5B0-4D55-4D74-9CEB-08C606B7CEB1Q42270797-31C4C4C0-2C8C-4C45-8FA1-312A20E4E225Q42357084-7B698319-3A0D-4D36-832A-D10D90A54E88Q43026378-02BEBD42-3200-4F53-8582-EE2D9783B18BQ43569902-B3A21824-EC47-47E6-BC06-C8CDE33E22A1Q45343578-0761D660-1597-4751-BF6E-8B35EFE6AA95Q45858020-31CDD8DD-4711-43A4-86E2-21E0D574C196Q45861683-DD8BA626-D120-4016-9577-415C131CB0A7Q45862128-32F6D2F8-7CA4-48D7-A07E-1779F4E9A725Q45864401-C6EDF2F1-3353-45A0-A89E-971E8907E355Q45866067-8B50FB20-8254-4A86-90A5-7BC326FD53A4Q45869508-B65E0990-7D0A-4F3B-87A2-051DF2A290BCQ45872203-ACEF7416-390F-4C45-9E8F-F3704B9DB296Q45872338-602E025C-C31B-4EED-B62E-2BC015F142F6Q45872843-54335565-B18E-499D-AFDE-79AAFB59E291Q45873794-6FA4E90D-2AF4-48DE-966D-8A1C25E5B793Q45880852-A9D1EA73-13C8-4D3A-BD4B-AD4D80C7C41CQ45881550-3980D0B1-4A18-435C-859F-67E114FDAE84Q46810398-68152004-390E-4D94-B395-42F0E25CC05DQ48204138-5AC6FA77-39DA-4AB9-B34A-19CC2A7105B6Q48283673-73943191-1A91-4992-A29F-60A1BDE39F12Q48378570-E21E220C-FA71-4340-8EBB-B85CB39FF758Q53167725-BCAD2703-3007-42B5-9245-994AA91FCC0AQ55710004-75DD16F7-4D85-4B21-8D7F-AA7B29D8CDF5Q57471711-F1CDC5B2-5E9B-427F-975D-783BC5EC31F4Q57479917-C41C4242-D05F-4A5B-B573-6D8916C0B882Q61040725-1EF9905F-AC82-4E6B-BD56-85B324A2EEA1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Andrea Artoni
@en
Andrea Artoni
@nl
type
label
Andrea Artoni
@en
Andrea Artoni
@nl
prefLabel
Andrea Artoni
@en
Andrea Artoni
@nl
P31
P496
0000-0003-0625-8320